Minireviews
Copyright ©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 109801
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.109801
Figure 1
Figure 1 Scleral icterus as a biomarker for cirrhosis and advanced liver disease.
Figure 2
Figure 2 Dry eye disease as a biomarker for hepatitis C.
Figure 3
Figure 3 Xanthelasma as a biomarker for cholestatic liver disease.